Tomas Kiselak

CIK 1830177 · last filed 2026-06-11

Tomas Kiselak is a corporate insider who has filed 18 SEC Form 4 insider transactions across 8 companies since 2020. The most recent filing, for APGE, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$512.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $237.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$237.05M

Companies

8

Total Filings

18

Lifetime Open-Market Net

-$512.88M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
APGE Director 51,166 $88.33 $4.52M -$534.10M 3 2026-06-11
SYRE Director 406,038 $80.79 $32.80M $0 2 2026-05-29
Damora Therapeutics, Inc. (GLTO) Delisted 10%+ Owner 2,904,000 $28.69 $83.32M $0 1 2026-02-12
ORKA Director 2,573,308 $69.89 $179.85M $0 1 2025-09-19
VRDN Director $16.35 $0 6 2025-07-02
DNTH Director 0 $82.07 $0 $815.0K 3 2024-10-01
ZBIO Director 1,003,814 $19.80 $19.88M $20.40M 1 2024-09-16
Viridian Therapeutics, Inc.\DE (MGEN) Delisted Director $0 1 2020-10-29

Recent Filings

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-11 APGE Grant (A) $0 EDGAR
2026-05-29 SYRE Grant (A) $0 EDGAR
2026-02-12 Damora Therapeutics, Inc. (GLTO) Delisted Exer (M) +43,565,000 $0 EDGAR
2026-01-22 APGE Sell (S) −7,000,000 -$534.10M EDGAR
2025-09-19 ORKA Grant (A) +1,666,700 $25.00M EDGAR
2025-07-02 VRDN Grant (A) $0 EDGAR
2024-10-01 DNTH Other (J) −124,292 $0 EDGAR
2024-09-16 ZBIO Mixed +6,419,564 $20.40M EDGAR
2024-06-28 VRDN Grant (A) $0 EDGAR
2024-05-28 DNTH Grant (A) $0 EDGAR
Showing 110 of 18
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.